China campaign cracks down on medical device rule breakers
This article was originally published in SRA
The China Food and Drug Administration is launching a five-month enforcement campaign to clamp down on five types of prevalent and serious acts of misconduct by medical device manufacturers1.
You may also be interested in...
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.
The risk of developing meningioma with cyproterone-containing medicines is rare, but it is serious enough to merit restrictions on how such products are used, according to the European Medicines Agency.
The European Medicines Agency has agreed to review pan-EU marketing applications for a number of new medicines.